Annual Debt To Equity
-0.26
+1.10+80.88%
31 December 2023
Summary:
Brainstorm Cell Therapeutics annual debt to equity ratio is currently -0.26, with the most recent change of +1.10 (+80.88%) on 31 December 2023. During the last 3 years, it has fallen by -0.46 (-230.00%). BCLI annual debt to equity is now -125.24% below its all-time high of 1.03, reached on 31 March 2003.BCLI Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-0.14
+0.13+48.15%
30 September 2024
Summary:
Brainstorm Cell Therapeutics quarterly debt to equity ratio is currently -0.14, with the most recent change of +0.13 (+48.15%) on 30 September 2024. Over the past year, it has increased by +0.98 (+87.50%). BCLI quarterly debt to equity is now -100.27% below its all-time high of 51.67, reached on 31 December 2003.BCLI Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI Debt To Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +80.9% | +87.5% |
3 y3 years | -230.0% | -163.6% |
5 y5 years | -100.0% | +64.1% |
BCLI Debt To Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -200.0% | +80.9% | -104.4% | +89.7% |
5 y | 5 years | -200.0% | +80.9% | -104.4% | +89.7% |
alltime | all time | -125.2% | +80.9% | -100.3% | +89.7% |
Brainstorm Cell Therapeutics Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -0.14(-48.1%) |
June 2024 | - | -0.27(+35.0%) |
Mar 2024 | - | -0.20(-23.1%) |
Dec 2023 | -0.26(-80.9%) | -0.26(-76.8%) |
Sept 2023 | - | -1.12(+31.8%) |
June 2023 | - | -0.85(+11.8%) |
Mar 2023 | - | -0.76(-44.1%) |
Dec 2022 | -1.36(-623.1%) | -1.36(-143.2%) |
Sept 2022 | - | 3.15(+425.0%) |
June 2022 | - | 0.60(+57.9%) |
Mar 2022 | - | 0.38(+46.2%) |
Dec 2021 | 0.26(+30.0%) | 0.26(+18.2%) |
Sept 2021 | - | 0.22(+10.0%) |
June 2021 | - | 0.20(+11.1%) |
Mar 2021 | - | 0.18(-10.0%) |
Dec 2020 | 0.20(-205.3%) | 0.20(+233.3%) |
Sept 2020 | - | 0.06(-66.7%) |
June 2020 | - | 0.18(-18.2%) |
Mar 2020 | - | 0.22(-215.8%) |
Dec 2019 | -0.19(<-9900.0%) | -0.19(-51.3%) |
Sept 2019 | - | -0.39(-38.1%) |
June 2019 | - | -0.63(-106.7%) |
Mar 2019 | - | 9.34(>+9900.0%) |
Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2018 | - | 0.00(0.0%) |
June 2018 | - | 0.00(0.0%) |
Mar 2018 | - | 0.00(0.0%) |
Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2017 | - | 0.00(0.0%) |
June 2017 | - | 0.00(0.0%) |
Mar 2017 | - | 0.00(0.0%) |
Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2016 | - | 0.00(0.0%) |
June 2016 | - | 0.00(0.0%) |
Mar 2016 | - | 0.00(0.0%) |
Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2015 | - | 0.00(0.0%) |
June 2015 | - | 0.00(0.0%) |
Mar 2015 | - | 0.00(0.0%) |
Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2014 | - | 0.00(0.0%) |
June 2014 | - | 0.00(0.0%) |
Mar 2014 | - | 0.00(0.0%) |
Dec 2013 | 0.00 | 0.00(0.0%) |
Sept 2013 | - | 0.00(0.0%) |
June 2013 | - | 0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2013 | - | 0.00(0.0%) |
Dec 2012 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2012 | - | 0.00(0.0%) |
June 2012 | - | 0.00(0.0%) |
Mar 2012 | - | 0.00(0.0%) |
Dec 2011 | 0.00(-100.0%) | 0.00(0.0%) |
Sept 2011 | - | 0.00(0.0%) |
June 2011 | - | 0.00(0.0%) |
Mar 2011 | - | 0.00(-100.0%) |
Dec 2010 | -0.30(+42.9%) | -0.30(+328.6%) |
Sept 2010 | - | -0.07(<-9900.0%) |
June 2010 | - | 0.00(-100.0%) |
Mar 2010 | - | 3.00(-1528.6%) |
Dec 2009 | -0.21(0.0%) | -0.21(+110.0%) |
Sept 2009 | - | -0.10(+11.1%) |
June 2009 | - | -0.09(-50.0%) |
Mar 2009 | - | -0.18(-14.3%) |
Dec 2008 | -0.21(-66.7%) | -0.21(-19.2%) |
Sept 2008 | - | -0.26(-3.7%) |
June 2008 | - | -0.27(-52.6%) |
Mar 2008 | - | -0.57(-9.5%) |
Dec 2007 | -0.63(+1.6%) | -0.63(-11.3%) |
Sept 2007 | - | -0.71(+16.4%) |
June 2007 | - | -0.61(0.0%) |
Mar 2007 | - | -0.61(-23.8%) |
Dec 2006 | -0.62(+933.3%) | - |
Sept 2006 | - | -0.80(-39.8%) |
June 2006 | - | -1.33(+2116.7%) |
Mar 2006 | - | -0.06(<-9900.0%) |
Mar 2006 | -0.06(<-9900.0%) | - |
Dec 2005 | - | 0.00(0.0%) |
Sept 2005 | - | 0.00(0.0%) |
June 2005 | - | 0.00(0.0%) |
Mar 2005 | 0.00(0.0%) | 0.00(0.0%) |
Dec 2004 | - | 0.00(0.0%) |
Sept 2004 | - | 0.00(0.0%) |
June 2004 | - | 0.00(0.0%) |
Mar 2004 | 0.00(-100.0%) | 0.00(-100.0%) |
Dec 2003 | - | 51.67(+716.3%) |
Sept 2003 | - | 6.33(+268.0%) |
June 2003 | - | 1.72(+67.0%) |
Mar 2003 | 1.03(+442.1%) | 1.03(+45.1%) |
Dec 2002 | - | 0.71(-22.0%) |
Sept 2002 | - | 0.91(-2.2%) |
June 2002 | - | 0.93 |
Mar 2002 | 0.19 | - |
FAQ
- What is Brainstorm Cell Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?
What is Brainstorm Cell Therapeutics annual debt to equity ratio?
The current annual debt to equity of BCLI is -0.26
What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual debt to equity ratio is 1.03
What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?
Over the past year, BCLI annual debt to equity ratio has changed by +1.10 (+80.88%)
What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of BCLI is -0.14
What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly debt to equity ratio is 51.67
What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?
Over the past year, BCLI quarterly debt to equity ratio has changed by +0.98 (+87.50%)